TrialThe Journal of infectious diseases2011

Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

Rex Biedenbender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.